123 related articles for article (PubMed ID: 15668623)
1. Variable designs of clinical trials of neuromuscular blocking agents: an example of studies comparing rocuronium and vecuronium.
Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Antonio-Ocampo A; Salmerón J
Med Sci Monit; 2005 Feb; 11(2):PI22-30. PubMed ID: 15668623
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
[TBL] [Abstract][Full Text] [Related]
3. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
Arain SR; Kern S; Ficke DJ; Ebert TJ
Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
[TBL] [Abstract][Full Text] [Related]
4. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
Ma H; Zhuang X
Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
[TBL] [Abstract][Full Text] [Related]
5. Cisatracurium versus vecuronium: a comparative, double blind, randomized, multicenter study in adult patients under propofol/fentanyl/N2O anesthesia.
Melloni C; Devivo P; Launo C; Mastronardi P; Novelli GP; Romano E
Minerva Anestesiol; 2006 May; 72(5):299-308. PubMed ID: 16675938
[TBL] [Abstract][Full Text] [Related]
6. A comparison of rocuronium and vecuronium: the pharmacodynamic, cardiovascular and intra-ocular effects.
Robertson EN; Hull JM; Verbeek AM; Booij LH
Eur J Anaesthesiol Suppl; 1994; 9():116-21. PubMed ID: 7925202
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
[TBL] [Abstract][Full Text] [Related]
8. Onset and recovery of rocuronium (Org 9426) and vecuronium under enflurane anaesthesia.
Mayer M; Doenicke A; Hofmann A; Peter K
Br J Anaesth; 1992 Nov; 69(5):511-2. PubMed ID: 1361356
[TBL] [Abstract][Full Text] [Related]
9. Priming studies with rocuronium and vecuronium.
Redai I; Feldman SA
Eur J Anaesthesiol Suppl; 1995 Sep; 11():11-3. PubMed ID: 8556997
[TBL] [Abstract][Full Text] [Related]
10. Sugammadex: the first selective binding reversal agent for neuromuscular block.
Kovac AL
J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
[TBL] [Abstract][Full Text] [Related]
11. Improved neuromuscular blockade using a novel neuromuscular blockade advisory system: a randomized, controlled, clinical trial.
Gilhuly TJ; Macleod BA; Dumont GA; Bouzane AM; Schwarz SK
Anesth Analg; 2008 Nov; 107(5):1609-17. PubMed ID: 18931219
[TBL] [Abstract][Full Text] [Related]
12. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
Caldwell JE; Szenohradszky J; Segredo V; Wright PM; McLoughlin C; Sharma ML; Gruenke LD; Fisher DM; Miller RD
J Pharmacol Exp Ther; 1994 Sep; 270(3):1216-22. PubMed ID: 7932174
[TBL] [Abstract][Full Text] [Related]
13. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
[TBL] [Abstract][Full Text] [Related]
14. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
[TBL] [Abstract][Full Text] [Related]
15. A pharmacodynamic basis for the peak effect of vecuronium: peak twitch versus peak tetanic fade.
Tripathi M; Tripathi M
J Indian Med Assoc; 2002 Aug; 100(8):491-2, 494, 501. PubMed ID: 12675179
[TBL] [Abstract][Full Text] [Related]
16. The agreement between adductor pollicis mechanomyogram and first dorsal interosseous electromyogram. A pharmacodynamic study of rocuronium and vecuronium.
Engbaek J; Roed J; Hangaard N; Viby-Mogensen J
Acta Anaesthesiol Scand; 1994 Nov; 38(8):869-78. PubMed ID: 7887113
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of neuromuscular blocking and circulatory effects of vecuronium bromide and pancuronium bromide by a double blind study].
Sugai N; Inada Y; Goto Y; Hashimoto Y; Kaya K; Suzuki H; Iwai S; Murakami S; Kosaka F; Ebihara A
Masui; 1986 Apr; 35(4):563-71. PubMed ID: 2875196
[No Abstract] [Full Text] [Related]
18. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
Stout RG; Shine TS; Silverman DG; Brull SJ
Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M
Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
[TBL] [Abstract][Full Text] [Related]
20. An update on sugammadex sodium.
Welliver M; Cheek D
AANA J; 2009 Jun; 77(3):219-28. PubMed ID: 19645172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
